For citations:
Kosorukov V.S., Abuzarova G.R., Zakharochkina E.R., Gamzeleva O.Yu., Yatsenko K.A. Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. Head and Neck Tumors (HNT). 2022;12(2):89-107. (In Russ.) https://doi.org/10.17650/2222-1468-2022-12-2-89-107
Email this article 